FirsthandHealth
FDA MedWatch Safety AlertsUnited States19 November 2026

FDA Issues Safety Alert for B. Braun Caresite Micro Luer Access Devices Due to Sticking Valves

The Food and Drug Administration issued an early alert on November 19, 2026, regarding a potential safety issue with B. Braun Medical Inc.'s Caresite Micro Luer Access Devices. On November 13, 2026, the manufacturer sent a letter instructing healthcare facilities to update how they use these medical valves. The devices provide a needle-free path to deliver or withdraw blood, intravenous fluids, and medications. B. Braun received reports that an internal piston can stick in an open position after a connector is removed. This sticking happens because the company confirmed a lack of silicone lubricant on the piston. An open valve can cause fluid or blood leakage, medication loss, or air entering the bloodstream. Vulnerable patients, such as newborn babies and critically ill individuals, face the highest risks from fluid loss or air embolisms. As of November 3, 2026, B. Braun reported no serious injuries or deaths linked to this problem.

What was announced

The Food and Drug Administration posted an alert on November 19, 2026, about B. Braun Medical Inc. updating instructions for its Caresite Micro Luer Access Devices under component number S5404000. These needle-free valves help clinical staff transfer fluids, blood, or medications to patients through vascular lines.

B. Braun notified customers on November 13, 2026, after receiving complaints that the internal piston stayed pushed down after removing a male connector. The company identified that silicone lubricant was missing from the piston area. Without lubricant, the valve can remain open. The manufacturer instructed clinical staff to visually check the devices after disconnecting lines and replace any valve showing leaks, backflow, or an unreturned piston.

What it means

When the internal piston sticks open, fluids or blood can leak out, and air can enter the fluid pathway. This failure creates risks of blood loss, delayed therapies, or air embolisms. An air embolism occurs when air enters the bloodstream, which can cause severe health consequences or death in rare cases.

Patients who need continuous life-sustaining treatments, as well as newborn infants and children, face higher risks from unexpected therapy interruptions or blood loss. Facilities must post B. Braun's notice in storage and break rooms and alert clinical staff during meetings. Healthcare staff must replace faulty standalone valves, or replace the whole extension set if the valve is permanently attached to it.

What the announcement does not tell us

The announcement does not state how many total devices are affected by the missing silicone lubricant. It does not explain how the lubricant was omitted during manufacturing or whether quality control steps have changed to fix the issue.

The FDA does not specify how long it will take to complete its review of the issue. Additionally, the notice does not say if B. Braun will offer refunds or automatic replacements for the faulty units.

How this was written

This analysis was written with AI from the official announcement below, using only facts that announcement states. The quoted wording is FDA MedWatch Safety Alerts’s own. Always check the original before acting on anything here.

BBMI corrects Caresite devices due to issue with internal piston remaining depressed following disconnection, preventing the valve from fully closing.
Source: FDA MedWatch Safety Alerts

More from FDA MedWatch Safety Alerts

This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.